NEWS

May 15, 2018

"Affinity Bio Partners and HCXP selected for Cannavalon Biosciences Proof of Concept Epilepsy Clinical Study"

PRESS RELEASE – May 15, 2018 9:00 AM/PM EASTERN

 

Cannavalon Biosciences, Inc.

 

"Affinity Bio Partners and HCXP selected for Cannavalon Biosciences Proof of Concept Epilepsy Clinical Study"

 

LOCATION Santa Cruz, California. --(BUSINESS WIRE)— Cannavalon Biosciences, Inc. announced today that it has selected Affinity Bio Partners, LLC as their Clinical Research Organization and their technology partner, HCXP for its upcoming Proof of Concept Epilepsy Study.

 

“Selecting a CRO is a crucial and very important step prior to initiating patient enrollment into our Proof of Concept clinical study of ELYSIUM CBD BASE in the treatment of Epilepsy." said Bill Arnold, Chief Executive Officer of Cannavalon BioSciences. "We see Affinity Bio Partners as the ideal CRO partner for this important clinical trial – their extensive expertise and capabilities in managing clinical studies in the CBD clinical industry will be a tremendous asset to us. With the utilization of HCXP’s technology, we will be able to see real-time electronic patient reportable outcome data for this study." said Paul Swanson, Chief Operating Officer, Chief Technology Officer, Co-Founder.

 

About Cannavalon Biosciences

 

Cannavalon Biosciences, Inc. is a vertically-integrated, Northern-California cannabis company based in Santa Cruz that operates growing and processing facilities in the world-famous, Sonoma County

appellation. Cannavalon’s core disciplines include cannabinoid research, science-to-sale operations, and product validation. Their expertise is derived from a decade (since 2007) of growing and oil extraction experience and five years (since 2012) of cannabinoid research and testing through their mergers with Vinea Labs, Inc. and Elysium Wellness Non-Profit. For more information on the company or general inquiries, please email: barnold@Cannavalon.com or visit us at https://www.Cannavalon.com.

     .

 

About Affinity Bio Partners (ABP)

 

Affinity Bio Partners (ABP) is a Clinical Research Organization (CRO) which offers clinical trial services and provides the transformational foundation for their clients which leverages their visionary, industry leading, professional staff. ABP provides itself in working with clients that have been in clinical research for decades, newly developed biotech's/nutraceutical/CBD/Medical Cannabis companies. With their entrepreneurial foundation, they are always forward thinking, innovative and risk anticipating. For more information on the company or general inquiries, please email: info@affinitybiopartners.com or visit us at www.affinitybiopartners.com. Follow us on twitter at inf03006608, Facebook, LinkedIn and Instagram.

 

About HCXperience Inc. (HCXP)

 

HCXP is a Pennsylvania based technology company that provides innovative healthcare solutions and services. HCXP has clients and partners throughout the country working in tandem to impact change and how healthcare experience data is captured/reported. Visit: http://hcxpinc.com and follow HCXP on Twitter (@HCXperience), LinkedIn and Facebook.

Please reload

Cannavalon Biosciences, Inc.  Santa Rosa, California 95404

  • Google+ - White Circle
  • White Twitter Icon
  • White Instagram Icon
  • White Facebook Icon

© 2019 Cannavalon Biosciences, Inc.  All Rights Reserved.